Consumers are being urged to be extra vigilant following reports of scams by rogue CBD companies.
Elderly people and those with long-term health conditions are being targeted by ‘unscrupulous’ CBD brands making false claims online.
A number of people have reported having considerable sums of money taken from their bank account after being persuaded to sign up for a free trial by companies claiming to be endorsed by Sir David Attenborough.
Adverts on social media and elsewhere online used photos of Attenborough without permission to promote CBD oil, while also making a number of unsubstantiated medical claims.
One advert stated that CBD is known to ‘support the nutritional health of aging bodies’, while another claims to ‘relieve chronic pain’, ‘reduce anxiety’ and ‘lower blood sugar’.
Pat, 73, (who asked us not to use her surname) told Cannabis Health that more than £160 was taken from her bank after she was taken in by a company called Canzana.
Pat, who has overcome cancer and has mobility issues following a knee replacement, says the advert appeared in her email inbox and the photo of Attenborough caught her attention.
“I’d been thinking about taking CBD for a while after having cancer and prior to that, a knee replacement. All the cancer drugs have really affected my joints and an osteopath recommended I try CBD during my treatment,” she said.
“Due to my profession I wanted to make sure I stayed within the law, so when I saw the picture of David Attenborough, I immediately thought it must be legitimate because he wouldn’t put his face on something that was illegal.”
The company appears to offer people a free sample of CBD oil by asking them to sign up for a trial period, they are then asked to enter payment details to cover the cost of delivery.
“At the time I was slightly worried about having to give them my credit card details, but I thought the worst that can happen is I might lose the £3 delivery charge,” continued Pat.
“I thought how am I ever going to find out about this stuff if I don’t try it? So I took a leap of faith.
“There was no mention of any kind of contractual obligation or further payment.”
Pat’s bank statement shows two transactions of £3.25 and then £4.75 went out of her account on 28 September.
The package arrived the following week containing CBD gummies and a bottle of CBD hemp oil.
But a few days later the same company made a request for payment of £85 and then another for £82, which was stopped by her bank after it raised concerns.
Several other members of CBD user support groups on Facebook also told Cannabis Health that the same thing had happened to them.
A spokesperson for David Attenborough has now confirmed that he has no involvement with these companies.
In a statement they said: “Sir David Attenborough has been appalled to discover companies are using his name and image to advertise CBD oil on Facebook and elsewhere online. These are not genuine endorsements and Sir David has had no involvement whatsoever with these products.
“The companies do not have permission to use Sir David’s name or image – Sir David only allows the use of his name and image for marketing in connection with his own programmes and books.”
Mary Biles, a cannabis journalist and author of The CBD Book, warned people to be wary of free trials online saying there is ‘always a catch’.
“People buying CBD for the first time are often in a vulnerable situation and I think it’s disgusting that they are targeted by unscrupulous companies like Canzana using false celebrity endorsements to lure them in,” she said.
“It’s important consumers realise that whenever a CBD company offers some sort of free trial there is always a catch involved and may lead to them being signed up unknowingly to a subscription scheme which may then be difficult to get out of.
“It goes without saying these kinds of companies are highly unlikely to be selling safe, quality CBD products as they clearly have no concern about the wellbeing of their customers.”
Mary added: “For anyone new to CBD, it’s always advisable to choose from companies that are transparent and ethical about where their CBD is sourced, provide detailed descriptions of their products (including certificates of analysis from a third party laboratory for each batch), and make no wild medical claims on their website.”
Meanwhile Sian Phillips, managing director of the Cannabis Trades Association (CTA) confirmed she was aware of the companies in question and urged consumers to be extra vigilant when buying CBD products online.
She commented: “The general public have to be so careful about who they buy their CBD products from.
“Make sure the company you are dealing with makes no medical claims on their website or social media, that they follow MHRA (Medicines and Healthcare products Regulatory Agency) regulations and always look out for the CTA membership logo on their website.
“Any company making medical claims is obviously using that to boost sales and that is frowned on by the rest of the industry.”
Molson Coors brings first CBD beverage to US
Mega brewer Molson Coors has announced its new line of non-alcoholic, sparkling CBD beverages in the US and it expands ‘beyond the beer aisle’.
The joint venture between brewing giant Molson Coors Beverage Company and Canadian cannabis firm HEXO Corp has announced its first US CBD drink will hit the market this month.
Launched by Truss CBD, Veryvell is a new line of non-alcoholic, sparkling CBD beverages, available exclusively for consumers in Colorado.
It marks the company’s first entry into the American CBD market since its inception and is another example of Molson Coors’ moves to cultivate the company’s beverage offerings.
“Last year we redefined ourselves as Molson Coors Beverage Company and in doing so, laid out a clear vision of leveraging the competitive strengths of our storied foundation in beer to grow in new spaces beyond the beer aisle,” said Pete Marino, president of the emerging growth division for Molson Coors.
“Truss’ entry into the CBD market in Colorado and the launch of Veryvell, a brand we believe will resonate well with Colorado consumers, is another example of Molson Coors’ expansion into new beverage categories.”
Veryvell has been described as having a crisp taste, containing zero calories, zero sugar and comes in three distinct varieties, each infused with 20mg of hemp-derived, non-psychoactive CBD and adaptogens.
These include, Focus, a combination of grapefruit and tarragon, Mind & Body, a blend of strawberry and hibiscus and Unwind, a mix of blueberry and lavender with ashwagandha and L-Theanine.
Jane Armstrong Hockman, Truss CBD USA general manager commented: “Whether you’ve dabbled in CBD before or are curious to try something new, Veryvell invites a moment of self-care to your day through a refreshing and balanced mix of hemp extracts and natural flavours.
“Each beverage in the product line offers a unique blend of CBD and adaptogens, giving consumers the freedom to pick the combination that best meets them in the moment. We are thrilled to bring our beverage expertise and commitment to quality to this emerging wellness category.
Veryvell is produced and distributed exclusively within Colorado, following the state’s established regulatory framework for hemp-derived CBD in food and beverages.
The diversification of the Molson Coors portfolio also includes an exclusive agreement with The Coca Cola Company to manufacture, market, and distribute Topo Chico Hard Seltzer in the US as well as an expanding roster of non-alcoholic innovations.
This includes a new energy drink being launched by a multi-faceted team of fitness, health and beverage industry change makers including Dwayne “The Rock” Johnson.
Follow @liveveryvell on Facebook and Instagram or visit www.trusscbdusa.com/
CBD and anxiety: What the research says
With more and more people reporting the use of CBD to ease stress and anxiety in these uncertain times, is the research there to back it up?
With a global pandemic raging, and many of us cut off from our friends and loved ones, it is no surprise that levels of anxiety and stress are at a high right now.
With many of our traditional stress-relieving activities – going to the gym, seeing a friend, travelling – out of bounds, and concern mounting about a rise in alcohol use, people are increasingly looking for alternative ways to relax.
A number of recent developments have once again highlighted the value of CBD in treating anxiety – so much so that a Canadian firm is developing a prescription drug based on the compound.
EmpowerPharm Inc is currently developing a unique prescription drug containing synthetic CBD as the active pharmaceutical ingredient to treat anxiety.
Pending the results of clinical research, it is thought the drug may help the thousands of Canadians who suffer from anxiety, as the firm has identified a growing need for innovative therapies as alternative treatments to avoid the addictive prescription products currently prescribed.
Meanwhile, CBD is also growing in popularity among those using it on a more recreational basis; almost half of UK users have increased their consumption since the pandemic.
A recent poll has found that more than a third (33 per cent) of Britons have tried CBD products, while 42 per cent have increased their usage since the outbreak of Covid-19, with anxiety the most common reason for using them.
While CBD has long had a reputation for promoting relaxation, research is still ongoing.
A landmark study in the US – billed as the first of its kind – was launched in October last year to investigate CBD’s use as a formal anxiety treatment.
The Cannabinoid Anxiety Relief Education Study is targeting millions of CBD and cannabis users across the US to assess the potential role of cannabinoids in reducing anxiety and other co-morbid conditions, such as insomnia and depression.
Such large-scale research is especially relevant given high Covid-19-caused anxiety levels, with many state and local governments deeming cannabis businesses “essential” and thus able to remain open during restrictions.
However, there are concerns that, while CBD can certainly help to relieve anxiety in the short-term, it is nothing more than a ‘sticking plaster’ solution.
Studies conducted by a team at Washington State University, led by phycology professor Dr Carrie Cuttler, analysed data from hundreds of people who recorded their symptoms before and after cannabis consumption.
Findings showed that in people who self-reported as having PTSD, cannabis reduced the severity of intrusive thoughts by about 62 per cent; for irritability it was 67 per cent and anxiety by 57 per cent.
However, researchers also found that there is no indication that cannabis reduced symptoms in the long-term.
Dr Cuttler cautioned: “We see a general theme that immediately after using cannabis most of the symptoms of these conditions are reduced by just over 50 percent.
“The bottom line is that it can work as an effective mask of the symptoms temporarily but it’s not benefiting the individuals in the long term.”
Such research points to the fact that, whole CBD may not be a solution for long-term anxiety, it is a useful took for treating shorter spells of stress – such as those caused by the pandemic.
US cannabis veteran launches pure CBD range
Cannabis entrepeneur, Jason Navarrete, who has almost two decades of experience in the sector, has launched a range of highly bio-available CBD products.
After selling his multi-million cannabis empire, US businessman, Navarrete has announced the launch of his new CBD range.
Navarrete is well-known in the industry having built a huge cannabis conglomerate in Southern California over the last 18 years.
Worth more than $250 million, the 120,000 square feet facility, across three industrial warehouses, focuses on high-tech hydroponic indoor cultivation, manufacturing, distribution and retail.
He sold the empire in early 2020 and transitioned from cultivating cannabis to creating what he claims are the purest CBD products on the market with his newest venture, Pure Craft CBD.
Pure Craft products are 90 percent bio-available, where most of those on the market are no more than 18 percent.
The company says being highly bio-available means Pure Craft products enter the body at a much quicker rate and are more effective than other products because they are broken down into particles that the body can absorb immediately.
Navarrete worked closely with MIT researchers to cultivate the cannabis and develop the line that includes nano-optimised broad spectrum water-soluble CBD tinctures along with soft gels, vegan gummies, CBD pet tincture, CBD broad spectrum oil and CBD with melatonin to promote sleep.
The team is also working on a full line of nano water-soluble tinctures from 600 – 3,000mg, in peppermint, tropical, strawberry mojito, orange cream, blueberry and vanilla flavours.
Navarrete believes the CBD industry is lacking the experience of cultivation experts, such as himself.
“When it comes to CBD, a lot of companies online are looking at the money aspect of an emerging industry,” he says.
“I’ve been cultivating cannabis for eighteen years. This industry is sorely lacking cultivation experts. That’s why scientists have reached out to work with me in their research.”
Navarrete explains a key factor in how he oversees his “seed to sale” process.
“We only partner with farmers that understand the importance of genetics and science in regard to cultivating premium hemp biomass.
“Our products are made following the strictest guidelines and quality control measures, allowing us to call them pharmaceutical grade.”
He is also sharing that wisdom with young entrepreneurs as an adjunct professor at the Center for Entrepreneurship at California State University, Fullerton, where he teaches young entrepreneurs about business basics.
“I’ve learned these lessons the hard way,” he explains.
“Teaching these young students the insights, skills and tricks of the trade makes me feel as if I am contributing to their entrepreneurial dreams to help them become more successful faster. The way I look at it, everything is a game and how much money you make is how you keep score.”
Pure Craft CBD offers 16 different cannabis products, which all come with third-party lab COAs (Certificates of Analysis) so consumers know exactly what’s in them and how they were tested every time.
News6 months ago
NHS lines up cannabis medicine manufacturing
News2 months ago
Community extends support to cannabis icon Rick Simpson
Case Studies10 months ago
CBD oil and fibromyalgia – a case study
Insight3 months ago
I’ve gone from a wheelchair to walking thanks to cannabis
Feature7 months ago
Medical cannabis could help long-term effects of COVID-19, says David Nutt
News4 months ago
“I’m not a bad person” – chronically ill woman convicted of growing medical cannabis
News4 months ago
Cancer survivor claims cannabis oil helped her beat brain tumour
News4 months ago
Mum of three-year-old with ‘one in a million’ condition fights for medical cannabis funding